PtCo alloy@cobalt benzoate/graphene (PtCo@Co‐BA/Gr) composite catalyst with 0D/1D/2D multidimensional structure is presented with simple solvothermal approach. As the introduced critical carrier, benzoic acid cobalt (II) (Co‐BA) has porous channels matching the size of platinum (Pt) nanoparticles and can enable PtCo alloy particles to be formed in its 1D mesopores through in situ reduction. Experiments indicate that the hydroxyl (OH) groups on the outer surface of Co‐BA are beneficial to form a strong interaction between Co‐BA and graphene. Compared with commercial Pt/C catalyst, the prepared PtCo@Co‐BA/Gr composite catalysts display an enlarged electrochemically active surface area, enhanced catalytic activity, and prolonged durability in acidic media toward the oxidation of various alcohols, such as methanol, ethanol, and ethylene glycol, which is mainly due to the increased surface area of PtCo by the confinement of mesoporous Co‐BA fiber, the promotion of water molecule dissociation of Co‐BA skeleton, and the improvement of conductivity by the introduction of graphene.
A novel 1D/2D/3D multidimensional catalyst, which is constructed by PtCo alloy nanoparticles, colalt benzoate nanofibers, and graphene layers, exhibited significant electrocatalytic enhancement and durability extension in variety alcohol oxidation. More details can be found in article number 1900946 by Ping Bai, Zhanli Chai, and co‐workers.
TiO2 is one of the most promising anode materials for lithium ion batteries (LIBs) due to its safe working potentials and small volume changes during lithium insertion/extraction. However, the inherent...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.